• Kennedy is available to explain how new variants of SARS-CoV-2, including the omicron variant, arise and how we can use this knowledge to reduce the burden of disease.
  • He can comment on the various evolutionary trajectories that SARS-CoV-2 may take in the future, and how vaccines, drugs and other selection pressures could influence those trajectories.

David Kennedy’s research focuses on investigating how pathogens, including viruses and bacteria, evolve. He is particularly interested in how selection pressures, such as drugs and vaccines, may influence this evolution. This knowledge can be used to delay, prevent, or reverse adverse evolutionary outcomes, such as drug and vaccine resistance.

Need help finding an expert?

Penn State expertise spans far beyond those that we have currently featured on the site. Call us at 814-865-7517 or contact a member of the media relations staff

Go to top